📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor. (2024)

First Author: Huang X

Attributed to: Allostery-driven G protein selectivity in the adenosine A1 receptor funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.4c01092

PubMed Identifier: 39073853

Publication URI: http://europepmc.org/abstract/MED/39073853

Type: Journal Article/Review

Volume: 67

Parent Publication: Journal of medicinal chemistry

Issue: 15

ISSN: 0022-2623